ABL1 and acute lymphoblastic leukemia: Our analysis suggests the existence of dedifferentiating transitions to a CD34+/CD38− stem cell–like immunophenotype in leukemia samples collected from patients with B-ALL, and the tendency for these transitions is especially strong in B-ALL with BCR::ABL1.